An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease

Recruiting now · Phase 3

Conditions studied: The Study Will Focus on Assessing the Survival Benefit on an Enhanced Package of Care for Patients With Advanced HIV Disease

In brief

A community-based Phase III, cluster randomized trial that seeks to determine the 24 week survival with retention in care of point of care CD4 testing with visitect and an enhanced package of screening and prophylaxis for opportunistic infections among patients with advanced HIV disease.

Key facts

Study ID

NCT05085171

Run by

Makerere University

People needed

2400

Starts

2022-05-04

Expected to finish

2027-09-01

Last updated by the study team

2022-07-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years
• CD4<200 cells/µL
• Ability and willingness to give informed consent for the enhanced package of care arm.

You may not qualify if…

• Known virologic suppression (viral load <1000 copies/mL) within prior 3 months
• Cannot or unlikely to attend regular clinic visits

Where it is running

• kisugu health center IV — Kampala, Uganda (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.